Literature DB >> 16847636

Tamoxifen citrate for women with unexplained infertility.

Tarek A Shokeir1.   

Abstract

OBJECTIVE: To assess whether administration of tamoxifen citrate (TMX) to women with unexplained infertility is beneficial. The primary outcome was the clinical pregnancy rate. STUDY
DESIGN: In a prospective randomized trial, 66 consecutive women with unexplained infertility were recruited for the study. Thirty-six women received TMX at a 20-mg dosage and 30 women received no ovulation-induction drugs.
RESULTS: Fourteen patients in the TMX group stopped taking TMX, and observations were terminated because of antiestrogenic effects. The pregnancy rate (PR) per patient and the PR per cycle were significantly decreased (P < 0.005) in the TMX group than in the spontaneous group. Kaplan-Meier tests showed that the cumulative PR in the TMX group was significantly lower than in the spontaneous group (P < 0.05). Ten of 14 patients who had stopped taking TMX became pregnant in spontaneous cycles.
CONCLUSIONS: Administration of tamoxifen to women with unexplained infertility is not efficacious in terms of increasing the clinical PR.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16847636     DOI: 10.1007/s00404-006-0181-8

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  2 in total

1.  Oral Drugs for Unexplained Infertility.

Authors:  Gautam N Allahbadia
Journal:  J Obstet Gynaecol India       Date:  2015-11-13

2.  Interventions for unexplained infertility: a systematic review and network meta-analysis.

Authors:  Rui Wang; Nora A Danhof; Raissa I Tjon-Kon-Fat; Marinus Jc Eijkemans; Patrick Mm Bossuyt; Monique H Mochtar; Fulco van der Veen; Siladitya Bhattacharya; Ben Willem J Mol; Madelon van Wely
Journal:  Cochrane Database Syst Rev       Date:  2019-09-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.